Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$65.5M
-1.9% from 2023
Prescriptions
125K
$523.82 per claim
Patients
31K
22,498 prescribers
Total spending, 2024
$65.5M
$2,101.59 per patient
Medicare prescription drug plans paid $65.5M for Bevespi Aerosphere in 2024, for 125,057 prescriptions and refills to 31,168 patients (down 1.9% from 2023). The average cost per claim was $523.82.
Ohio had the highest Medicare cost for Bevespi Aerosphere in 2024: $4.6M for 8,962 claims, followed by New York ($4.5M).
Thomas P Hooker, pulmonary disease in Hendersonville, NC, had the highest Medicare cost for Bevespi Aerosphere in 2024: 344 claims costing $159K.
Bevespi Aerosphere is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Thomas P Hooker Hendersonville, NC | Pulmonary Disease | 344 | 85 | $159K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 184 | 58 | $157K |
| Ladly Abraham |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 21,875 | 127,402 | 30,190 | $69.4M |
| 2023 | 21,371 | 118,335 | 28,679 | $66.8M |
| 2024 | 22,498 | 125,057 | 31,168 | $65.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 139 |
| 42 |
| $73K |
| Zulfiqar Ahmed Glendale, CA | Pulmonary Disease | 148 | 33 | $62K |
| Kelly L Dudley Augusta, ME | Nurse Practitioner | 70 | 27 | $61K |
| Susan C Winterbauer Rockford, IL | Nurse Practitioner | 90 | 25 | $59K |
| Anand Kommuri Davenport, IA | Pulmonary Disease | 117 | 24 | $58K |
| Bryson P Stair Columbus, OH | Nurse Practitioner | 109 | 21 | $49K |
| Annette M Esper Atlanta, GA | Pulmonary Disease | 95 | 27 | $49K |
| Bharat Upadhyay Port St Lucie, FL | Pulmonary Disease | 82 | 21 | $48K |
| Chaim J Bernstein Brooklyn, NY | Pulmonary Disease | 100 | 25 | $48K |
| Milledge C Newton Jr. Valdosta, GA | Pulmonary Disease | 78 | 22 | $47K |
| Ganesha Santhyadka Bangor, ME | Pulmonary Disease | 91 | 18 | $47K |
| Usman A Cheema Galesburg, IL | Pulmonary Disease | 71 | 17 | $46K |
| Andrea Feng New York, NY | Pulmonary Disease | 108 | 25 | $45K |
| Amanda D Holley Cortland, NY | Nurse Practitioner | 64 | 16 | $44K |
| Ginger Davis Lancaster, OH | Nurse Practitioner | 88 | 20 | $44K |
| Philip Slocum Joplin, MO | Pulmonary Disease | 91 | 18 | $43K |
| Shahla G Naoman Batesville, AR | Pulmonary Disease | 96 | 24 | $42K |
| Danielle Wisen Willoughby, OH | Physician Assistant | 83 | 22 | $42K |
| Emilia N Anigbo Newark, OH | Pulmonary Disease | 87 | 13 | $40K |
| Gretchen S Rossiter Zanesville, OH | Nurse Practitioner | 84 | 14 | $39K |
| Stefanie Nunez Renton, WA | Pulmonary Disease | 59 | 11 | $39K |
| Moin A Ranginwala Springfield, OH | Pulmonary Disease | 67 | 18 | $38K |
| Brian D Lindsay Cedar Rapids, IA | Pulmonary Disease | 88 | 16 | $37K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 125,109 | $65.5M |